The results indicated that RENT3B expression was significantly associated with eight types of cancers: blood tumor, brain cancer, breast cancer, colorectal cancer, lung cancer, ovarian cancer, skin cancer, and soft tissue tumor (Fig. 2). Here, UPF3B is linked to ovarian carcinoma.